Patents by Inventor Makgorzata Witek

Makgorzata Witek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9952212
    Abstract: This invention provides methods and compositions for capturing circulating tumor cells (CTCs) as well as various divergent CTC phenotypes using seprase-specific affinity reagents. Methods of analyzing CTCs and assessing their metastatic potential in vivo and in vitro are also disclosed.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: April 24, 2018
    Assignees: Roche Molecular Systems, Inc., The University of North Carolina Chapel Hill
    Inventors: George Martin, Steven Soper, Makgorzata Witek, Jen Jen Yeh
  • Publication number: 20160139116
    Abstract: This invention provides methods and compositions for capturing circulating tumor cells (CTCs) as well as various divergent CTC phenotypes using seprase-specific affinity reagents. Methods of analyzing CTCs and assessing their metastatic potential in vivo and in vitro are also disclosed.
    Type: Application
    Filed: December 18, 2015
    Publication date: May 19, 2016
    Inventors: George Martin, Steven Soper, Makgorzata Witek, Jen Jen Yeh
  • Patent number: 9250242
    Abstract: This invention provides methods and compositions for capturing circulating tumor cells (CTCs) as well as various divergent CTC phenotypes using seprase-specific affinity reagents. Methods of analyzing CTCs and assessing their metastatic potential in vivo and in vitro are also disclosed.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: February 2, 2016
    Assignees: ROCHE MOLECULAR SYSTEMS, INC., THE UNIVERSITY OF NORTH CAROLINA
    Inventors: George Martin, Steven Soper, Makgorzata Witek, Jen Jen Yeh
  • Publication number: 20140134646
    Abstract: This invention provides methods and compositions for capturing circulating tumor cells (CTCs) as well as various divergent CTC phenotypes using seprase-specific affinity reagents. Methods of analyzing CTCs and assessing their metastatic potential in vivo and in vitro are also disclosed.
    Type: Application
    Filed: November 8, 2013
    Publication date: May 15, 2014
    Applicants: ROCHE MOLECULAR SYSTEMS, INC., THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, BIOFLUIDICA, INC
    Inventors: George Martin, Steven Soper, Makgorzata Witek, Jen Jen Yeh